Soreq Avigal 4
4 · Delek US Holdings, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Soreq Avigal
DirectorPresident & CEO
Transactions
- Sale
Common Stock
[F1][F2]2026-03-03$41.71/sh−13,768$574,263→ 287,910 total - Sale
Common Stock
[F1][F3]2026-03-03$40.90/sh−34,332$1,404,179→ 253,578 total - Sale
Common Stock
[F1][F4]2026-03-03$39.85/sh−1,900$75,715→ 251,678 total
Footnotes (4)
- [F1]This transaction was made pursuant to a 10b5-1 plan adopted on December 3, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
- [F2]The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $41.36 per share to a high sale price of $42.35 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- [F3]The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $40.34 per share to a high sale price of $41.34 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
- [F4]The price reflects the weighted average sale price of multiple transactions ranging from a low sale price of $39.70 per share to a high sale price of $40.33 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each sale price.
Signature
/s/ Misty Lavender, Attorney in Fact|2026-03-05